Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emotional facial expression recognition in treatment-resistant major depressive episode treated with low-frequency right dorsolateral prefrontal rTMS and/or venlafaxine
2009-014056-30Phase 2Active
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of venlafaxine in major depressive disorder (MDD) (4 arms), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Started Aug 2009; status: active.
02
Drugs
venlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2009-014056-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014056-30.